Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)

Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)

Purpose: Given the importance of understanding the genetic variations involved in the pathogenesis of non-Hodgkin’s lymphoma (NHL), this work was designed to study the impact of IL-10 (−1082 G/A; rs1800896 and −819 C/T; rs1800871) gene promoter polymorphism on susceptibility of Egyptians to diffuse...

Full description

Bibliographic Details
Main Authors:	Roba M. Talaat, Amal M. Abdel-Aziz, Eman A. El-Maadawy, Naser Abdel-Bary
Format:	Article
Language:	English
Published:	SpringerOpen 2014-01-01
Series:	Egyptian Journal of Medical Human Genetics
Subjects:	NHL DLBCL SNP IL-10 ELISA
Online Access:	http://www.sciencedirect.com/science/article/pii/S1110863013000633

Similar Items

Primary Paratesticular Lymphoma with Testicular Sparing: Account of an Unusual Scrotal Mass
by: Vidya Monappa, et al.
Published: (2016-03-01)

Head and neck lymphomas – a retrospective ten-year observation
by: Marcelina Niemiec, et al.
Published: (2017-03-01)

Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma
by: Pedro S. de Carvalho, et al.
Published: (2021-04-01)

The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients
by: Hikmat Abdel-Razeq, et al.
Published: (2021-05-01)

A rare CD5-positive subgroup of diffuse large B-cell lymphoma – clinical, morphological and immunophenotypic features in Polish patients
by: Nina Woźnialis, et al.
Published: (2016-11-01)

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
by: Jun Zhang, et al.
Published: (2018-09-01)

Dissecting and Modeling Oncogene Dependent Molecular Mechanisms in Lymphoma Genesis and Progression
by: Hand, Elisabeth
Published: (2013)

BRIDGING TO TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA
by: Christian Gisselbrecht, et al.
Published: (2016-07-01)

The prevalence of Hepatitis C Virus Infection in sample of Iraqi Patients With Non -Hodgkin′s Lymphoma
by: Qudus Wamidh Jamal
Published: (2015-01-01)

Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling
by: Ryan N. Rys, et al.
Published: (2021-02-01)

Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma
by: Jéssica Arribas Arranz, et al.
Published: (2018-03-01)

Follicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse—a case report
by: M. C. Suresh Babu, et al.
Published: (2020-05-01)

Polymorphisms in the interleukin-10 gene and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases
by: Zahra Armingohar, et al.
Published: (2015-02-01)

Elucidation of the Mechanisms of Resistance and Sensitivity to Histone Deacetylase Inhibitor, PXD101, in Diffuse Large B-Cell Lymphoma (DLBCL)
by: Tula Sanchez, Ana A.
Published: (2013)

Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas
by: Chramostova, K., et al.
Published: (2022)

ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
by: Amineh Ghaderi, et al.
Published: (2020-06-01)

The Tumor Microenvironment of DLBCL in the Computational Era
by: Giuseppina Opinto, et al.
Published: (2020-03-01)

Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature
by: N G GABEEVA, et al.
Published: (2018-07-01)

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients
by: Susanna Tokola, et al.
Published: (2020-03-01)

Characterization of Interleukin 10 gene variations and serum levels as predictive factors for the clinical outcome of Non-Hodgkin Lymphoma patients and Analysis of molecular mechanisms of Interleukin 10 gene regulation in B cells
by: Heemann, Christina
Published: (2013)

Expression of N6-methyladenosine (m6A) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL)
by: Zucheng Xie, et al.
Published: (2021-01-01)

Expression of IL‐34 correlates with macrophage infiltration and prognosis of diffuse large B‐cell lymphoma
by: Osamu Noyori, et al.
Published: (2019-01-01)

New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT
by: Anne-Ségolène Cottereau, et al.
Published: (2021-08-01)

Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
by: Guido Lancman, et al.
Published: (2018-01-01)

IQGAP2 acts as an independent prognostic factor and is related to immunosuppression in DLBCL
by: Tianjiao Tang, et al.
Published: (2021-05-01)

Is there a correlation between -174(G/C) polymorphism of IL-6 gene and the incidence of acute myocardial infarction?
by: Ingy M. Hashad, et al.
Published: (2021-09-01)

Treating Early-Stage DLBCL on the FLYER: What Lesson for Radiation Therapy?
by: Kelsey Sokol, et al.
Published: (2021-06-01)

Interleukin 18 gene promoter polymorphisms in Latvian patients with rheumatoid arthritis
by: Mihailova Anna, et al.
Published: (2011-01-01)

IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis
by: Elisa Ferretti, et al.
Published: (2018-03-01)

Efficacy of therapy of different variants of anaplastic large t-cell lymphomas
by: Iu E Vinogradova, et al.
Published: (2008-07-01)

Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL
by: Shuanglong Fan, et al.
Published: (2021-01-01)

Polymorphisms in DNA Repair Genes and MDR1 and the Risk for Non-Hodgkin Lymphoma
by: Hee Nam Kim, et al.
Published: (2014-04-01)

Expression et rôle d’HSP110 dans le lymphome B diffus à grandes cellules de type activé ou ABC-DLBCL
by: Boudesco, Christophe
Published: (2018)

SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population
by: Yutian Kan, et al.
Published: (2018-10-01)

Fine-needle aspiration diagnosis of extranodal non-Hodgkin′s lymphoma of the tongue
by: Srinivasa Murthy, et al.
Published: (2011-01-01)

Association of polymorphisms in TP53 and the promoter region of IL10 with gastric cancer in a Kazakh population
by: Gulmira Kulmambetova, et al.
Published: (2020-07-01)

Influence of tumor location on the composition of immune infiltrate and its impact on patient survival. Lessons from DLBCL and animal models.
by: Claire eGaland, et al.
Published: (2012-05-01)

Metachronous carcinoma cervix in a treated case of Non-Hodgkins Lymphoma -A rare case report
by: Dr. P.Masthan Basha, et al.
Published: (2019-01-01)

Proteomic-Based Analysis of Hypoxia- and Physioxia-Responsive Proteins and Pathways in Diffuse Large B-Cell Lymphoma
by: Kamila Duś-Szachniewicz, et al.
Published: (2021-08-01)

Prognostic evaluation of PET/CT in residual post-chemotherapy masses in patients with diffuse large B-cell lymphoma and its impact on survival
by: Dina M. ABO-Sheisha, et al.
Published: (2014-09-01)